Prenetics Global (PRE) FCF Margin (2021 - 2026)
Prenetics Global (PRE) posted quarterly FCF Margin of 37.21% for Q1 2026, up 1227.0% year-over-year from 2.8% in Q1 2025, and up 32.27% quarter-over-quarter from 54.94% in Q4 2025.
Prenetics Global (PRE) FCF Margin (2021 - 2026) Analysis & Trends
Prenetics Global (PRE) has reported FCF Margin for 2 consecutive years, with 37.21% the latest figure, recorded in Q1 2026.
- In Q1 2026, FCF Margin rose 1227.0% year-over-year to 37.21%; the TTM figure through Mar 2026 stood at 33.41% (down 1040.0% YoY), while the FY2025 annual figure was 45.27%, up 14223.0% from the prior year.
- FCF Margin improved to 37.21% in Q1 2026 per PRE's latest filing, from 54.94% in the prior quarter.
- Across five years, FCF Margin topped out at 29.62% in Q2 2025 and bottomed at 54.94% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 13.97% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 20.19% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -1.15% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 10.95% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 8.24% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 26.51% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 13.89% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 27.51% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 8.41% |
| 10 | Prenetics Global | 368.73 Mn | 309.68 Mn | 30.20 Mn | -33.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -33.98% |
| Mar 31, 2026 | -33.72% |
| Jun 30, 2025 | -44.12% |
| Mar 31, 2025 | -48.06% |
| Dec 31, 2024 | -433.45% |
| Sep 30, 2024 | -334,702,947.85% |
| Dec 31, 2023 | -264.81% |
| Sep 30, 2023 | -182,277,813.98% |
| Dec 31, 2022 | -15.15% |
| Dec 31, 2021 | 68,196.92% |